NLRP3 and atherosclerosis: In mice, macrophage NLRP3 inflammasome activation worsens atherosclerosis (12), especially when hypercholesterolemia is accompanied by additional pro-inflammatory processes such as diabetes, clonal hematopoiesis (CH), or defective cholesterol efflux (10).